Communication is one of the major skills covered in cognitive behavioral therapy. Although therapy is often with an individual, relationship problems are a common focus of treatment. Helping someone ...

Cognitive behavioral therapy for insomnia, or CBT-I, is a short-term, highly structured form of therapy used to treat chronic insomnia. Like other forms of CBT, CBT-I targets a client’s maladaptive ...

Taylor Leamey wrote about all things wellness for CNET, specializing in mental health, sleep and nutrition coverage. She has invested hundreds of hours into studying and researching sleep and holds a ...

As if having cancer wasn’t hard enough, up to 50% of patients and survivors also suffer from insomnia or other sleep disturbances, says Eugenie Spiguel, an advanced practice provider at Memorial Sloan ...

Aversion therapy (AT) is a behavioral therapy that involves repeatedly pairing an undesirable behavior with an unpleasant experience with the goal of discouraging the undesirable behavior. Other names ...

DBT was originally developed to help people with thoughts of suicide manage overwhelming distress. DBT teaches you to replace unhelpful behaviors with skills like mindfulness and distress tolerance.

Breanna Mona is a freelance writer and editor focused on creating inclusive, empathetic content. She works across platforms like Healthline, Greatist, Medical News Today, Psych Central and more, ...

During cognitive behavioral therapy (CBT) for alcohol use disorder (AUD), a person may discuss factors that contribute to their condition and learn alternative coping mechanisms. AUD is a form of ...

The approach is used to help people with a variety of conditions, including chronic pain disorders, which affect about 50.2 million adults in the United States. With CBT, a mental health expert leads ...

Going to therapy is an essential part of true self-care. It’s a process that helps people understand themselves better. Therapy provides tools to navigate the often stormy world of relationships, ...

Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics Among N = 300 patients, 74.7% was female, 76.5% was White, and 19.0% was ...